EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment

Zhengping Che, Wei Wang, Lin Zhang, Zhenghong Lin

Journal of Pharmaceutical Analysis · 2025-01 · 15 (1) · 101099

DOI: 10.1016/j.jpha.2024.101099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2025-01. Verfasst von Zhengping Che und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Chongqing University, Chongqing, 401331, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal (GI) cancers are prevalent globally, with leading incidence and mortality rates among malignant tumors. Despite notable advancements in surgical resection, radiotherapy, and chemotherapy, the overall survival rates remain low. Hence, it is imperative to explore alternative approaches that enhance patient outcomes. Cluster of differentiation 47 (CD47), serving as an early diagnostic marker, is predominantly overexpressed in GI cancers and associated with poor prognosis. Targeting the CD47-signal regulatory protein alpha (SIRPα) signaling pathway may provide a novel strategy for GI cancers treatment. This study summarizes current knowledge of the structure and function of CD47 and SIRPα, their roles in signaling pathways, the prognostic significance of CD47, therapeutic strategies targeting the CD47-SIRPα signaling pathway in GI cancer, and highlights key issues for future investigations.

Schlagwörter

Stichwörter der Autor:innen

CD47-SIRPαGI cancersImmune checkpoint blockadeImmunotherapySignaling pathway

Autor:innen und Institutionen

  • School of Life Sciences, Chongqing University, Chongqing, 401331, China.
  • Department of Cancer Center, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing, 404000, China.
  • Department of Gastroenterology, Chongqing University Jiangjin Hospital, Chongqing, 402260, China.

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission

Zitieren

APA

Che, Z., Wang, W., Zhang, L., & Lin, Z. (2025). Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment. Journal of Pharmaceutical Analysis, 15(1), 101099. https://doi.org/10.1016/j.jpha.2024.101099

Vancouver

Che Z, Wang W, Zhang L, Lin Z. Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment. Journal of Pharmaceutical Analysis. 2025;15(1):101099. doi:10.1016/j.jpha.2024.101099

BibTeX
@article{Che2025,
  author = {Che, Zhengping and Wang, Wei and Zhang, Lin and Lin, Zhenghong},
  title = {Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {101099},
  doi = {10.1016/j.jpha.2024.101099}
}
Kostenlos starten →